AIDS	Acquired immunodeficiency syndrome
ARVT	Antiretroviral therapy
BIC	Bictegravir
BSA	Benzenesulfonic acid
CDI	1,1′-Carbonyldiimidazole
DABCO	1,4-Diazabicyclo[2.2.2]octane
DCE	1,2-Dichloroethane
DCM	Dichloromethane
DEEMM	Diethyl ethoxymethylenemalonate
DFBA	2,4-Difluorobenzyl amine
DIAD	Diisopropyl azodicarboxylate
DIPEA	N,N-Diisopropylethylamine
DMA	Dimethylacetamide
DMAD	Dimethyl acetylenedicarboxylate
DMADMF	Dimethylformamide dimethyl acetal
DMF	Dimethylformamide
DMSO	Dimethylsulfoxide
DPPP	1,3-Bis(diphenylphosphino)propane
DTG	Dolutegravir
EC50	Half maximal effective concentration
EDC (EDCI)	1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
EMME	Ethoxymethylenemalonic ester
EVG	Elvitegravir
FDA	Food and Drug Administration
FGI	Functional group interconversion
HATU	1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate
HIV	Human immunodeficiency virus
HOBt	Hydroxybenzotriazole
IC50	Half maximal inhibitory concentration
INI	Integrase inhibitor
MCPBA	Meta-chloroperoxybenzoic acid
NBS	N-Bromosuccinimide
NIS	N-Iodosuccinimide
NMM	N-Methylmorpholine
PIFA	Phenyliodine bis(trifluoroacetate)
PPA	Polyphosphoric acid
RAL	Raltegravir
TBHP	Tert-butyl hydroperoxide
TEA	Triethylamine
TFA	Trifluoroacetic acid
THF	Tetrahydrofuran